Status:
COMPLETED
Noninvasive Positive Pressure Ventilation During Neonatal Nasal Intubation
Lead Sponsor:
University of Zurich
Conditions:
Infant, Newborn, Diseases
Intubation Complication
Eligibility:
All Genders
Phase:
NA
Brief Summary
The goal of this study is to perform a quality control assessment of our local intubation protocol in any newborn infant requiring endotracheal intubation in the delivery room or neonatal intensive ca...
Eligibility Criteria
Inclusion
- Any neonate at the Department of Neonatology of the University Hospital Zurich undergoing endotracheal intubation in the delivery room or neonatal intensive care unit.
Exclusion
- Requirement for immediate endotracheal intubation as determined by the treating clinician, without time for potential application of NIPPV, e.g. active cardiopulmonary resuscitation.
- Contraindication to NIPPV use (e.g. congenital diaphragmatic hernia, abdominal wall defects).
- Oral intubation planned.
- Denial of parental consent and/or inability of the parents to understand the study procedures due to cognitive or linguistic reasons.
- Withdrawal at the discretion of the intubating clinician if he / she feels the study is interfering with a safe and optimal treatment of the patient.
Key Trial Info
Start Date :
March 31 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 5 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06139809
Start Date
March 31 2024
End Date
October 5 2025
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland